By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Wealth Beat NewsWealth Beat News
  • Home
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Notification Show More
Aa
Wealth Beat NewsWealth Beat News
Aa
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Follow US
Wealth Beat News > News > VYMI ETF: Ex-U.S. Stocks Boast Big Yields, Low Valuations
News

VYMI ETF: Ex-U.S. Stocks Boast Big Yields, Low Valuations

News
Last updated: 2023/12/03 at 4:21 PM
By News
Share
6 Min Read
SHARE

Contents
Ex-US Stocks Feature Big Dividends Compared to the S&P 500VYMI: Portfolio & Factor ProfilesVYMI: Holdings & Dividend InformationVYMI: Bullish Seasonal Trend Through Mid-JanuaryThe Technical TakeVYMI: Neutral Technical Factors, Improved MomentumThe Bottom Line

I never miss the monthly J.P. Morgan Guide to the Markets. One of my go-to charts is the refresh on the US vs ex-US stock market view. The MSCI All Country World Ex-US minus S&P 500 next 12-month dividend yield spread is now more than 1.8% – more than two standard deviations above the long-term average. It suggests that foreign stocks, particularly those with a solid yield, are relatively cheap.

I have a buy rating on the Vanguard International High Dividend Yield Index Fund ETF Shares (NASDAQ:VYMI) for its low valuation and solid long-term growth trends, though the chart has its concerns.

Ex-US Stocks Feature Big Dividends Compared to the S&P 500

Ex-US Stocks Feature Big Dividends Compared to the S&P 500

J.P. Morgan Asset Management

According to Vanguard, VYMI seeks to track the performance of the FTSE All-World ex US High Dividend Yield Index. The ETF provides investors with easy and low-cost access to international equities forecast to have above-average dividend yields. The fund employs a passively managed, sampling approach to portfolio allocation.

VYMI is a large ETF with more than $6.5 billion in assets under management and it pays a high 4.4% trailing 12-month dividend yield as of December 1, 2023. Share-price momentum has turned up in the last five weeks as equities have rebounded sharply, and I will point out some key indicators as we approach the end of the year.

Cost-conscious investors should appreciate the ETF’s low 0.22% annual expense ratio while VYMI’s risk ETF Grade is impressive at A- given its somewhat modest volatility readings. Finally, liquidity is strong considering the fund’s average daily trading volume of 345k shares and narrow 30-day median bid/ask spread of just three basis points.

Digging into the portfolio, VYMI features high exposure to the large-cap value space of the equity style box. The 4-star, silver-rated fund also has a significant amount of assets considered large-cap blend. With just 3% in the growth column and merely 13% of SMID-cap exposure, the ETF is somewhat concentrated, so paying attention to global cyclical growth trends is key given the multinational value weight. But take a look at the low 8.8x price-to-earnings ratio – that is less than half the multiple of the S&P 500 while VYMI’s long-term earnings growth rate is healthy at 8.6%, making for a PEG ratio near 1.

VYMI: Portfolio & Factor Profiles

VYMI: Portfolio & Factor Profiles

Morningstar

The reason for the modest valuation is a high allocation to the beaten-down Financials sector. More than a third of VYMI is made up of banks and other diversified financial services-type firms, but some of its largest holdings are actually in the Health Care and Energy sectors. There’s relatively little weight in the growth-heavy Information Technology area, so expect returns to vary significantly from the SPX. Finally, there is diversification in the sense that VYMI’s top 10 positions make up just 15% of the fund.

VYMI: Holdings & Dividend Information

VYMI: Holdings & Dividend Information

Seeking Alpha

Seasonally, VYMI tends to perform well from early December through mid-January, according to data from Equity Clock, so pouncing on the opportunity to purchase sooner rather than later to establish a long-term position could prove wise.

VYMI: Bullish Seasonal Trend Through Mid-January

VYMI: Bullish Seasonal Trend Through Mid-January

Equity Clock

The Technical Take

VYMI’s 7-year history has been frustrating for long-time holders. Notice in the chart below that the fund remains below its January 2018 peak just above the $72 mark. Shares failed to climb above that spot on a pair of rally attempts in mid-2021 and early 2022. Following a nearly 30% plunge in 2022, the ETF has bounced back but remains sharply below the all-time high. I see reason for hope going forward, though.

Take a look at the RSI momentum oscillator at the top of the graph. The momentum reading notched a multi-month high last Friday, rallying through a downtrend resistance line. Technicians widely believe that momentum comes before price, so the RSI move could portend a bullish advance in VYMI shares. But with a flat long-term 200-day moving average, there is no trend yet. What’s more, a high amount of volume by price up to about $68 could make it tough on the bulls in the near term. I see support in the low $50s, underscoring the reality of a trading range persisting.

Overall, the technical situation is mixed.

VYMI: Neutral Technical Factors, Improved Momentum

VYMI: Neutral Technical Factors, Improved Momentum

Stockcharts.com

The Bottom Line

I have a buy rating on VYMI. I like its low cost, strong liquidity, and exceptionally low valuation, though the technical situation is neutral despite improved momentum.

Editor’s Note: This article discusses one or more securities that do not trade on a major U.S. exchange. Please be aware of the risks associated with these stocks.

Read the full article here

News December 3, 2023 December 3, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Excelerate Energy: Nearby Best Energy-Source Cap-Gain Prospect (NYSE:EE)

The primary focus of this article is Excelerate Energy, Inc. (NYSE:EE). Investment…

Penske Is Steady, But The Road Ahead May Be Bumpy (NYSE:PAG)

Investing Thesis On Wednesday, Penske Automotive Group (NYSE:PAG) released a superficially encouraging…

Top Financial – No, Stop It, This Is Silly (NASDAQ:TOP)

TOP Financial Moves, yes, but why? TOP Financial (NASDAQ:TOP) was quite the…

You Might Also Like

News

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (July 2025)

By News
News

Webster Financial Stock: A Bit More Upside Is Warranted (NYSE:WBS)

By News
News

Zoom Stock: 30% Net Cash Position More Important Amidst Market Volatility (NASDAQ:ZM)

By News
News

EIDO: This Indonesian ETF Is A Very Poor Choice For Long-Term Oriented Investors (NYSEARCA:EIDO)

By News
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Contact US
More Info
  • Newsletter
  • Finance
  • Investing
  • Small Business
  • Dept Management

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions

Join Community

2025 © wealthbeatnews.com. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc.

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?